Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 155 Pages
Report ld: 5345043
Request Sample
Customized Report
The global Radiofrequency Ablation Therapy Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Radiofrequency ablation (RFA) is recognized as the most advanced fourth-generation physical therapy technology in the world. It has the advantages of minimally invasive, simple and precise curative effect. It has been recognized by both doctors and patients and has been widely developed at home and abroad.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Radiofrequency Ablation Therapy Device market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Radiofrequency Ablation Therapy Device study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Radiofrequency Ablation Therapy Device: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Radiofrequency Ablation Therapy Device Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 RF Generators
1.2.3 Reusable Products
1.2.4 Disposable Products
1.3 Market Segmentation by Application
1.3.1 Global Radiofrequency Ablation Therapy Device Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Radiofrequency Ablation Therapy Device Revenue Estimates and Forecasts 2020-2031
2.2 Global Radiofrequency Ablation Therapy Device Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Radiofrequency Ablation Therapy Device Sales Estimates and Forecasts 2020-2031
2.4 Global Radiofrequency Ablation Therapy Device Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Radiofrequency Ablation Therapy Device Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Radiofrequency Ablation Therapy Device Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 RF Generators Market Size by Manufacturers
3.5.2 Reusable Products Market Size by Manufacturers
3.5.3 Disposable Products Market Size by Manufacturers
3.6 Global Radiofrequency Ablation Therapy Device Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Radiofrequency Ablation Therapy Device Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Radiofrequency Ablation Therapy Device Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Radiofrequency Ablation Therapy Device Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Radiofrequency Ablation Therapy Device Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Radiofrequency Ablation Therapy Device Sales and Revenue by Type (2020-2031)
6.4 North America Radiofrequency Ablation Therapy Device Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Radiofrequency Ablation Therapy Device Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Radiofrequency Ablation Therapy Device Sales and Revenue by Type (2020-2031)
7.4 Europe Radiofrequency Ablation Therapy Device Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Radiofrequency Ablation Therapy Device Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Radiofrequency Ablation Therapy Device Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Radiofrequency Ablation Therapy Device Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Radiofrequency Ablation Therapy Device Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Radiofrequency Ablation Therapy Device Sales and Revenue by Type (2020-2031)
9.4 Central and South America Radiofrequency Ablation Therapy Device Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Radiofrequency Ablation Therapy Device Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Radiofrequency Ablation Therapy Device Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Radiofrequency Ablation Therapy Device Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Radiofrequency Ablation Therapy Device Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.1.4 Abbott Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Radiofrequency Ablation Therapy Device Sales by Product in 2024
11.1.6 Abbott Radiofrequency Ablation Therapy Device Sales by Application in 2024
11.1.7 Abbott Radiofrequency Ablation Therapy Device Sales by Geographic Area in 2024
11.1.8 Abbott Radiofrequency Ablation Therapy Device SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Avanos Medical
11.2.1 Avanos Medical Corporation Information
11.2.2 Avanos Medical Business Overview
11.2.3 Avanos Medical Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.2.4 Avanos Medical Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Avanos Medical Radiofrequency Ablation Therapy Device Sales by Product in 2024
11.2.6 Avanos Medical Radiofrequency Ablation Therapy Device Sales by Application in 2024
11.2.7 Avanos Medical Radiofrequency Ablation Therapy Device Sales by Geographic Area in 2024
11.2.8 Avanos Medical Radiofrequency Ablation Therapy Device SWOT Analysis
11.2.9 Avanos Medical Recent Developments
11.3 Stryker
11.3.1 Stryker Corporation Information
11.3.2 Stryker Business Overview
11.3.3 Stryker Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.3.4 Stryker Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Stryker Radiofrequency Ablation Therapy Device Sales by Product in 2024
11.3.6 Stryker Radiofrequency Ablation Therapy Device Sales by Application in 2024
11.3.7 Stryker Radiofrequency Ablation Therapy Device Sales by Geographic Area in 2024
11.3.8 Stryker Radiofrequency Ablation Therapy Device SWOT Analysis
11.3.9 Stryker Recent Developments
11.4 Boston Scientific
11.4.1 Boston Scientific Corporation Information
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.4.4 Boston Scientific Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Boston Scientific Radiofrequency Ablation Therapy Device Sales by Product in 2024
11.4.6 Boston Scientific Radiofrequency Ablation Therapy Device Sales by Application in 2024
11.4.7 Boston Scientific Radiofrequency Ablation Therapy Device Sales by Geographic Area in 2024
11.4.8 Boston Scientific Radiofrequency Ablation Therapy Device SWOT Analysis
11.4.9 Boston Scientific Recent Developments
11.5 Medtronic
11.5.1 Medtronic Corporation Information
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.5.4 Medtronic Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Medtronic Radiofrequency Ablation Therapy Device Sales by Product in 2024
11.5.6 Medtronic Radiofrequency Ablation Therapy Device Sales by Application in 2024
11.5.7 Medtronic Radiofrequency Ablation Therapy Device Sales by Geographic Area in 2024
11.5.8 Medtronic Radiofrequency Ablation Therapy Device SWOT Analysis
11.5.9 Medtronic Recent Developments
11.6 Diros Technology
11.6.1 Diros Technology Corporation Information
11.6.2 Diros Technology Business Overview
11.6.3 Diros Technology Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.6.4 Diros Technology Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Diros Technology Recent Developments
11.7 Mianyang Leading Electronic Technology
11.7.1 Mianyang Leading Electronic Technology Corporation Information
11.7.2 Mianyang Leading Electronic Technology Business Overview
11.7.3 Mianyang Leading Electronic Technology Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.7.4 Mianyang Leading Electronic Technology Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Mianyang Leading Electronic Technology Recent Developments
11.8 JJET
11.8.1 JJET Corporation Information
11.8.2 JJET Business Overview
11.8.3 JJET Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.8.4 JJET Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 JJET Recent Developments
11.9 Wuhan BBT Medical
11.9.1 Wuhan BBT Medical Corporation Information
11.9.2 Wuhan BBT Medical Business Overview
11.9.3 Wuhan BBT Medical Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.9.4 Wuhan BBT Medical Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Wuhan BBT Medical Recent Developments
11.10 Medsphere International
11.10.1 Medsphere International Corporation Information
11.10.2 Medsphere International Business Overview
11.10.3 Medsphere International Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.10.4 Medsphere International Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Medsphere International Recent Developments
11.11 Angel Medical
11.11.1 Angel Medical Corporation Information
11.11.2 Angel Medical Business Overview
11.11.3 Angel Medical Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.11.4 Angel Medical Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Angel Medical Recent Developments
11.12 Surgnova Healthcare Technologies
11.12.1 Surgnova Healthcare Technologies Corporation Information
11.12.2 Surgnova Healthcare Technologies Business Overview
11.12.3 Surgnova Healthcare Technologies Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.12.4 Surgnova Healthcare Technologies Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Surgnova Healthcare Technologies Recent Developments
11.13 Tianjin Simon Medical Technology
11.13.1 Tianjin Simon Medical Technology Corporation Information
11.13.2 Tianjin Simon Medical Technology Business Overview
11.13.3 Tianjin Simon Medical Technology Radiofrequency Ablation Therapy Device Product Models, Descriptions and Specifications
11.13.4 Tianjin Simon Medical Technology Radiofrequency Ablation Therapy Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Tianjin Simon Medical Technology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Radiofrequency Ablation Therapy Device Industry Chain
12.2 Radiofrequency Ablation Therapy Device Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Radiofrequency Ablation Therapy Device Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Radiofrequency Ablation Therapy Device Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Radiofrequency Ablation Therapy Device Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Radiofrequency Ablation Therapy Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Radiofrequency Ablation Therapy Device was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 140
USD 3950.00
(Single User License)
The global Radiofrequency Ablation Therapy Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 123
USD 2900.00
(Single User License)
The global Radiofrequency Ablation Therapy Device market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 97
USD 4250.00
(Single User License)
The global market for Radiofrequency Ablation Therapy Device was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 112
USD 3950.00
(Single User License)
The global market for Radiofrequency Ablation Therapy Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 90
USD 2900.00
(Single User License)
Radiofrequency ablation (RFA) is recognized as the most advanced fourth-generation physical therapy technology in the world. It has the advantages of minimally invasive, simple and precise curative effect. It has been recognized by both doctors and patients and has been widely developed at home and abroad.
Published Date: 2024-04-28
Pages: 111
USD 4900.00
(Single User License)
Radiofrequency ablation (RFA) is recognized as the most advanced fourth-generation physical therapy technology in the world. It has the advantages of minimally invasive, simple and precise curative effect. It has been recognized by both doctors and patients and has been widely developed at home and abroad.
Published Date: 2024-01-18
Pages: 96
USD 2900.00
(Single User License)
The global market for Radiofrequency Ablation Therapy Device was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 140
The global Radiofrequency Ablation Therapy Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 123
The global Radiofrequency Ablation Therapy Device market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 97
The global market for Radiofrequency Ablation Therapy Device was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 112
The global market for Radiofrequency Ablation Therapy Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 90
Radiofrequency ablation (RFA) is recognized as the most advanced fourth-generation physical therapy technology in the world. It has the advantages of minimally invasive, simple and precise curative effect. It has been recognized by both doctors and patients and has been widely developed at home and abroad.
Published: 2024-04-28
Pages: 111
Radiofrequency ablation (RFA) is recognized as the most advanced fourth-generation physical therapy technology in the world. It has the advantages of minimally invasive, simple and precise curative effect. It has been recognized by both doctors and patients and has been widely developed at home and abroad.
Published: 2024-01-18
Pages: 96
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now